XML 63 R53.htm IDEA: XBRL DOCUMENT v3.23.2
Transactions - Narrative (Details) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jan. 20, 2023
Aug. 01, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Business Acquisition [Line Items]              
Cash         $ 388,246,000 $ 9,070,000  
Discrete tax benefit     $ 970,000 $ 184,000 69,159,000 (1,018,000)  
Revenue [1]     469,136,000 319,939,000 896,826,000 616,996,000  
Net loss attributable to common shareholders of Evolent Health, Inc.     $ (34,323,000) $ (4,588,000) (54,305,000) $ (9,938,000)  
NIA              
Business Acquisition [Line Items]              
Total consideration $ 715,694,000            
Cash 387,823,000            
Fair value of Class A common stock issued 261,271,000            
Contingent consideration arrangements (up to) $ 150,000,000            
Percentage of contingent consideration allowed to be paid in equity interest (up to) 50.00%            
Contingent consideration $ 66,600,000            
Goodwill, expected tax deductible amount $ 0            
Discrete tax benefit         56,100,000    
Revenue         107,400,000    
Net loss attributable to common shareholders of Evolent Health, Inc.         $ (2,800,000)    
NIA | Common Class A              
Business Acquisition [Line Items]              
Equity interest issued or issuable, number of shares (in shares) 8,474,576            
NIA | Customer relationships              
Business Acquisition [Line Items]              
Estimated useful life 15 years            
NIA | Technology              
Business Acquisition [Line Items]              
Estimated useful life 5 years            
NIA | Corporate trade name              
Business Acquisition [Line Items]              
Estimated useful life 2 years            
IPG              
Business Acquisition [Line Items]              
Total consideration   $ 461,663,000          
Cash   $ 256,488,000          
Equity interest issued or issuable, number of shares (in shares)   3,700,000          
Fair value of Class A common stock issued   $ 130,175,000          
Contingent consideration arrangements (up to)   87,000,000          
Contingent consideration   75,000,000          
Goodwill, expected tax deductible amount   $ 0          
Discrete tax benefit             $ 46,800,000
Voting interests acquired   100.00%          
IPG | Customer relationships              
Business Acquisition [Line Items]              
Estimated useful life   20 years          
IPG | Technology              
Business Acquisition [Line Items]              
Estimated useful life   5 years          
IPG | Corporate trade name              
Business Acquisition [Line Items]              
Estimated useful life   15 years          
[1] See Note 18 for amounts attributable to unconsolidated related parties included in these line items.